SEC Form 4 · accession 0001209191-15-055364
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Schenkein
Director
Period of report
Jun 18, 2015
Accepted (ET)
Jun 22, 2015 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 18, 2015 | A | 5,997 | $32.23 | A | 11,251 | D | |
| Common StockF2 | holding | — | — | — | 5,254 | I | David P. Schenkein 2004 Revocable Trust | |
| Common StockF3 | holding | — | — | — | 5,254 | I | Amy P. Schenkein 2004 Revocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units granted by the Issuer pursuant to its 2013 Stock Option and Incentive Plan and the Issuer's Non-Employee Director Compensation Policy. The restricted stock units vest on the earlier of June 18, 2016 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board of Directors, or immediately upon the death or disability of the director or upon a change-of-control of the Issuer.
- F2These shares are held in a trust for the benefit of the Reporting Person. The Reporting Person is trustee of the trust.
- F3These shares are held in a trust for the benefit of the Reporting Person's spouse. The Reporting Person is trustee of the trust.